Merck & Co., Inc. Non-operating Income/Expense 2007-2026 | MRK
Beta
What is Merck & Co., Inc.'s current non-operating income/expense?
Merck & Co., Inc. (MRK) annual non-operating income/expense for 2025 was $-151.0M, a 729.17% decline from 2024. Merck & Co., Inc. non-operating income/expense for the quarter ending March 31, 2026 was $-138.0M.
What was Merck & Co., Inc.'s non-operating income/expense in 2024?
Merck & Co., Inc. annual non-operating income/expense for 2024 was $24.0M, a 105.15% increase from 2023.
What was Merck & Co., Inc.'s non-operating income/expense in 2023?
Merck & Co., Inc. annual non-operating income/expense for 2023 was $-466.0M, a 68.95% increase from 2022.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$890.0M
→
FY2025
$-151.0M
07080910111213141516171819202122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-151.0M | -729.2% | 10-K |
| FY2024 | $24.0M | +105.2% | 10-K |
| FY2023 | $-466.0M | +69.0% | 10-K |
| FY2022 | $-1.50B | -211.9% | 10-K |
| FY2021 | $1.34B | +50.7% | 10-K |
| FY2020 | $890.0M | +789.9% | 10-K |
| FY2019 | $-129.0M | -132.1% | 10-K |
| FY2018 | $402.0M | -19.6% | 10-K |
| FY2017 | $500.0M | +364.6% | 10-K |
| FY2016 | $-189.0M | +87.6% | 10-K |
| FY2015 | $-1.53B | -113.1% | 10-K |
| FY2014 | $11.61B | +2925.5% | 10-K |
| FY2013 | $-411.0M | +63.2% | 10-K |
| FY2012 | $-1.12B | -18.0% | 10-K |
| FY2011 | $-946.0M | +27.5% | 10-K |
| FY2010 | $-1.30B | -112.2% | 10-K |
| FY2009 | $10.67B | +360.2% | 10-K |
| FY2008 | $2.32B | +2982.4% | 10-K |
| FY2007 | $75.2M | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →